The breast imaging devices market size has grown strongly in recent years. It will grow from $5.27 billion in 2025 to $5.6 billion in 2026 at a compound annual growth rate (CAGR) of 6.3%. The growth in the historic period can be attributed to rising breast cancer screening awareness, expansion of diagnostic imaging centers, increasing availability of digital mammography systems, growing healthcare expenditure, adoption of advanced ultrasound technologies.
The breast imaging devices market size is expected to see strong growth in the next few years. It will grow to $7.24 billion in 2030 at a compound annual growth rate (CAGR) of 6.7%. The growth in the forecast period can be attributed to increasing investments in ai-enabled diagnostic tools, rising demand for early cancer detection solutions, expansion of outpatient imaging services, growing focus on personalized breast care, technological advancements in non-ionizing imaging systems. Major trends in the forecast period include increasing adoption of ai-assisted image analysis, rising use of 3D and digital breast tomosynthesis, growing integration of multimodal imaging platforms, expansion of minimally invasive diagnostic imaging, enhanced focus on early-stage cancer detection.
The expansion of the breast imaging device market is attributed to the escalating prevalence of breast cancer. Factors such as increased exposure to hormone replacement therapies (HRT), hormonal imbalances, menopause, and several reproductive disorders have significantly elevated the risk of breast cancer among individuals. Breast cancer stands as the most prevalent cancer affecting women globally, as per statistics from the World Health Organization (WHO), impacting approximately 2.1 million women annually. Additionally, it leads to the highest number of cancer-related fatalities among women. A recent report from the American Society of Clinical Oncology (ASCO) indicated that 1 in 3 new female cancer cases in the United States is diagnosed as breast cancer. In the year 2023, an estimated 297,790 women in the United States are expected to be diagnosed with invasive breast cancer and 55,720 with non-invasive (in situ) breast cancer.
Leading companies in the breast imaging devices market are concentrating on developing technologically advanced solutions, such as cutting-edge imaging techniques, to enhance early detection and improve diagnostic accuracy for breast cancer. Advanced imaging techniques refer to sophisticated methods that provide detailed and precise visualizations of the body's internal structures, including digital mammography, 3D tomosynthesis, and magnetic resonance imaging (MRI). For example, in October 2024, StoneSprings Hospital Centre, a US-based healthcare facility, introduced new breast imaging technology. This innovative technology employs state-of-the-art imaging modalities, such as digital mammography and 3D tomosynthesis, which deliver clearer and more detailed images of breast tissue. This advancement aids in detecting abnormalities that may not be visible through traditional 2D mammography. The system is designed to incorporate artificial intelligence (AI) algorithms to assist radiologists in more accurately interpreting images. AI can help by flagging potential areas of concern, thereby minimizing the risk of missed diagnoses and enhancing overall accuracy.
In May 2024, Lunit, a South Korea-based medical AI company specializing in software for cancer screening and treatment, acquired Volpara Health Technologies Limited for an undisclosed amount. Through this acquisition, Lunit aims to enhance its AI-driven cancer diagnostics, expand its presence in the U.S. market, and develop innovative solutions for early cancer detection and improved patient outcomes. Volpara Health Technologies Limited is a New Zealand-based software company that enhances breast imaging devices with cutting-edge software to improve cancer detection.
Major companies operating in the breast imaging devices market are Siemens Healthineers AG, Hologic Inc, GE Healthcare, FUJIFILM Holdings Corporation, Canon Medical Systems Corporation, Koninklijke Philips N.V, Aurora Imaging Technology Inc, Delphinus Medical Technologies Inc, Micrima Limited, SonoCiné Inc, Planmed Oy, Carestream Health Inc, Dilon Technologies Inc, Toshiba Medical Systems Corporation, SuperSonic Imagine SA, IMS Giotto (Giotto Imaging), Samsung Medison Co Ltd, Hitachi Ltd, Koning Corporation, Metaltronica S.p.A, CMT Medical Technologies Ltd, Gamma Medica Inc, KUB Technologies Inc.
North America was the largest region in the breast imaging devices market in 2025. Asia-Pacific was the second largest market in the global breast imaging devices market report. The regions covered in the breast imaging devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the breast imaging devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the breast imaging devices market by increasing costs of imported imaging sensors, semiconductors, X-ray tubes, magnets, and precision electronic components used in mammography, MRI, and ultrasound systems. Hospitals and diagnostic imaging centers in North America and Europe are most affected due to reliance on imported high-end imaging equipment, while Asia-Pacific faces higher manufacturing input costs. These tariffs are raising capital equipment prices and delaying procurement cycles for healthcare providers. However, they are also encouraging localized assembly, regional supplier development, and increased investment in domestic medical imaging manufacturing capabilities.
The breast imaging devices market research report is one of a series of new reports that provides breast imaging devices market statistics, including breast imaging devices industry global market size, regional shares, competitors with a breast imaging devices market share, detailed breast imaging devices market segments, market trends and opportunities, and any further data you may need to thrive in the breast imaging devices industry. This breast imaging devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Breast imaging devices are medical equipment crucial for screening, diagnosing, and supporting breast health, including cancerous and noncancerous breast diseases. These devices play a vital role in early detection and treatment of breast cancer.
Key product types in breast imaging devices include tomosynthesis, breast ultrasound, breast MRI, mammography, nuclear imaging, and others. Tomosynthesis is an imaging method employed for both screening and diagnostic purposes, particularly in individuals with or without symptoms of breast cancer. Breast imaging devices utilize ionizing and non-ionizing technologies. These devices find application in hospitals, clinics, breast care centers, and diagnostic imaging centers.
The breast imaging devices market consists of sales of imaging equipment such as breast ultrasound, breast MRI, mammography, nuclear imaging, and others. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The breast imaging devices market size is expected to see strong growth in the next few years. It will grow to $7.24 billion in 2030 at a compound annual growth rate (CAGR) of 6.7%. The growth in the forecast period can be attributed to increasing investments in ai-enabled diagnostic tools, rising demand for early cancer detection solutions, expansion of outpatient imaging services, growing focus on personalized breast care, technological advancements in non-ionizing imaging systems. Major trends in the forecast period include increasing adoption of ai-assisted image analysis, rising use of 3D and digital breast tomosynthesis, growing integration of multimodal imaging platforms, expansion of minimally invasive diagnostic imaging, enhanced focus on early-stage cancer detection.
The expansion of the breast imaging device market is attributed to the escalating prevalence of breast cancer. Factors such as increased exposure to hormone replacement therapies (HRT), hormonal imbalances, menopause, and several reproductive disorders have significantly elevated the risk of breast cancer among individuals. Breast cancer stands as the most prevalent cancer affecting women globally, as per statistics from the World Health Organization (WHO), impacting approximately 2.1 million women annually. Additionally, it leads to the highest number of cancer-related fatalities among women. A recent report from the American Society of Clinical Oncology (ASCO) indicated that 1 in 3 new female cancer cases in the United States is diagnosed as breast cancer. In the year 2023, an estimated 297,790 women in the United States are expected to be diagnosed with invasive breast cancer and 55,720 with non-invasive (in situ) breast cancer.
Leading companies in the breast imaging devices market are concentrating on developing technologically advanced solutions, such as cutting-edge imaging techniques, to enhance early detection and improve diagnostic accuracy for breast cancer. Advanced imaging techniques refer to sophisticated methods that provide detailed and precise visualizations of the body's internal structures, including digital mammography, 3D tomosynthesis, and magnetic resonance imaging (MRI). For example, in October 2024, StoneSprings Hospital Centre, a US-based healthcare facility, introduced new breast imaging technology. This innovative technology employs state-of-the-art imaging modalities, such as digital mammography and 3D tomosynthesis, which deliver clearer and more detailed images of breast tissue. This advancement aids in detecting abnormalities that may not be visible through traditional 2D mammography. The system is designed to incorporate artificial intelligence (AI) algorithms to assist radiologists in more accurately interpreting images. AI can help by flagging potential areas of concern, thereby minimizing the risk of missed diagnoses and enhancing overall accuracy.
In May 2024, Lunit, a South Korea-based medical AI company specializing in software for cancer screening and treatment, acquired Volpara Health Technologies Limited for an undisclosed amount. Through this acquisition, Lunit aims to enhance its AI-driven cancer diagnostics, expand its presence in the U.S. market, and develop innovative solutions for early cancer detection and improved patient outcomes. Volpara Health Technologies Limited is a New Zealand-based software company that enhances breast imaging devices with cutting-edge software to improve cancer detection.
Major companies operating in the breast imaging devices market are Siemens Healthineers AG, Hologic Inc, GE Healthcare, FUJIFILM Holdings Corporation, Canon Medical Systems Corporation, Koninklijke Philips N.V, Aurora Imaging Technology Inc, Delphinus Medical Technologies Inc, Micrima Limited, SonoCiné Inc, Planmed Oy, Carestream Health Inc, Dilon Technologies Inc, Toshiba Medical Systems Corporation, SuperSonic Imagine SA, IMS Giotto (Giotto Imaging), Samsung Medison Co Ltd, Hitachi Ltd, Koning Corporation, Metaltronica S.p.A, CMT Medical Technologies Ltd, Gamma Medica Inc, KUB Technologies Inc.
North America was the largest region in the breast imaging devices market in 2025. Asia-Pacific was the second largest market in the global breast imaging devices market report. The regions covered in the breast imaging devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the breast imaging devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the breast imaging devices market by increasing costs of imported imaging sensors, semiconductors, X-ray tubes, magnets, and precision electronic components used in mammography, MRI, and ultrasound systems. Hospitals and diagnostic imaging centers in North America and Europe are most affected due to reliance on imported high-end imaging equipment, while Asia-Pacific faces higher manufacturing input costs. These tariffs are raising capital equipment prices and delaying procurement cycles for healthcare providers. However, they are also encouraging localized assembly, regional supplier development, and increased investment in domestic medical imaging manufacturing capabilities.
The breast imaging devices market research report is one of a series of new reports that provides breast imaging devices market statistics, including breast imaging devices industry global market size, regional shares, competitors with a breast imaging devices market share, detailed breast imaging devices market segments, market trends and opportunities, and any further data you may need to thrive in the breast imaging devices industry. This breast imaging devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Breast imaging devices are medical equipment crucial for screening, diagnosing, and supporting breast health, including cancerous and noncancerous breast diseases. These devices play a vital role in early detection and treatment of breast cancer.
Key product types in breast imaging devices include tomosynthesis, breast ultrasound, breast MRI, mammography, nuclear imaging, and others. Tomosynthesis is an imaging method employed for both screening and diagnostic purposes, particularly in individuals with or without symptoms of breast cancer. Breast imaging devices utilize ionizing and non-ionizing technologies. These devices find application in hospitals, clinics, breast care centers, and diagnostic imaging centers.
The breast imaging devices market consists of sales of imaging equipment such as breast ultrasound, breast MRI, mammography, nuclear imaging, and others. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Breast Imaging Devices Market Characteristics
3. Breast Imaging Devices Market Supply Chain Analysis
4. Global Breast Imaging Devices Market Trends and Strategies
5. Breast Imaging Devices Market Analysis of End Use Industries
7. Global Breast Imaging Devices Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Breast Imaging Devices Total Addressable Market (TAM) Analysis for the Market
9. Breast Imaging Devices Market Segmentation
10. Breast Imaging Devices Market Regional and Country Analysis
11. Asia-Pacific Breast Imaging Devices Market
12. China Breast Imaging Devices Market
13. India Breast Imaging Devices Market
14. Japan Breast Imaging Devices Market
15. Australia Breast Imaging Devices Market
16. Indonesia Breast Imaging Devices Market
17. South Korea Breast Imaging Devices Market
18. Taiwan Breast Imaging Devices Market
19. South East Asia Breast Imaging Devices Market
20. Western Europe Breast Imaging Devices Market
21. UK Breast Imaging Devices Market
22. Germany Breast Imaging Devices Market
23. France Breast Imaging Devices Market
24. Italy Breast Imaging Devices Market
25. Spain Breast Imaging Devices Market
26. Eastern Europe Breast Imaging Devices Market
27. Russia Breast Imaging Devices Market
28. North America Breast Imaging Devices Market
29. USA Breast Imaging Devices Market
30. Canada Breast Imaging Devices Market
31. South America Breast Imaging Devices Market
32. Brazil Breast Imaging Devices Market
33. Middle East Breast Imaging Devices Market
34. Africa Breast Imaging Devices Market
36. Breast Imaging Devices Market Competitive Landscape and Company Profiles
37. Breast Imaging Devices Market Other Major and Innovative Companies
40. Breast Imaging Devices Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Breast Imaging Devices Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses breast imaging devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for breast imaging devices? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The breast imaging devices market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product Type: Tomosynthesis; Breast Ultrasound; Breast Magnetic Resonance Imaging (MRI); Mammography; Nuclear Imaging; Other Product Types2) By Technology: Ionizing; Non Ionizing
3) By End User: Hospitals And Clinics; Breast Care Centers; Diagnostic Imaging Centers
Subsegments:
1) By Tomosynthesis: Digital Breast Tomosynthesis (DBT); 3D Mammography Systems2) By Breast Ultrasound: Handheld Ultrasound; Automated Breast Ultrasound System (ABUS); Elastography
3) By Breast Magnetic Resonance Imaging (MRI): Contrast-Enhanced MRI; Functional MRI
4) By Mammography: Digital Mammography; Film Mammography; 2D Mammography
5) By Nuclear Imaging: Positron Emission Tomography (PET); Single Photon Emission Computed Tomography (SPECT)
6) By Other Product Types: Infrared Imaging; Molecular Imaging Systems; Stereotactic Breast Biopsy Devices
Companies Mentioned: Siemens Healthineers AG; Hologic Inc; GE Healthcare; FUJIFILM Holdings Corporation; Canon Medical Systems Corporation; Koninklijke Philips N.V; Aurora Imaging Technology Inc; Delphinus Medical Technologies Inc; Micrima Limited; SonoCiné Inc; Planmed Oy; Carestream Health Inc; Dilon Technologies Inc; Toshiba Medical Systems Corporation; SuperSonic Imagine SA; IMS Giotto (Giotto Imaging); Samsung Medison Co Ltd; Hitachi Ltd; Koning Corporation; Metaltronica S.p.A; CMT Medical Technologies Ltd; Gamma Medica Inc; KUB Technologies Inc
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Breast Imaging Devices market report include:- Siemens Healthineers AG
- Hologic Inc
- GE Healthcare
- FUJIFILM Holdings Corporation
- Canon Medical Systems Corporation
- Koninklijke Philips N.V
- Aurora Imaging Technology Inc
- Delphinus Medical Technologies Inc
- Micrima Limited
- SonoCiné Inc
- Planmed Oy
- Carestream Health Inc
- Dilon Technologies Inc
- Toshiba Medical Systems Corporation
- SuperSonic Imagine SA
- IMS Giotto (Giotto Imaging)
- Samsung Medison Co Ltd
- Hitachi Ltd
- Koning Corporation
- Metaltronica S.p.A
- CMT Medical Technologies Ltd
- Gamma Medica Inc
- KUB Technologies Inc
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 5.6 Billion |
| Forecasted Market Value ( USD | $ 7.24 Billion |
| Compound Annual Growth Rate | 6.7% |
| Regions Covered | Global |
| No. of Companies Mentioned | 24 |
